A biomarker trial of BR-DIM (BioResponse 3,3′-Diindolylmethane) in patients with prostate cancer who undergo prostatectomy.

被引：0
|
作者：
Heath, E. I.
Hwang, C.
Cher, M. L.
Heilbrun, L. K.
Powell, I.
Menon, M.
Li, J.
Heath, M.
Sethi, S.
Sarkar, F. H.
机构：
[1] Karmanos Canc Inst, Detroit, MI USA
[2] Henry Ford Hosp, Detroit, MI 48202 USA
[3] Wayne State Univ, Karmanos Canc Inst, Detroit, MI USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2011年 / 29卷 / 15期
关键词：
D O I：
10.1200/jco.2011.29.15_suppl.e15185
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e15185
引用
收藏
页数：1
相关论文
共 50 条
  • [1] The effects of BR-DIM (BioResponse 3, 3′-Diindolylmethane) administered pre-prostatectomy on the androgen receptor (AR)
    Heath, Elisabeth I.
    Hwang, Clara
    Cher, Michael L.
    Heilbrun, Lance K.
    Powell, Isaac
    Menon, Mani
    Li, Jing
    Chitale, Dhananjay
    Gupta, Nilesh
    Sethi, Seema
    Bolton, Susan
    Smith, Daryn W.
    Sarkar, Fazlul H.
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [2] A phase I dose-escalation study of oral BR-DIM (BioResponse 3,3′-Diindolylmethane) in castrate-resistant, non-metastatic prostate cancer
    Heath, Elisabeth I.
    Heilbrun, Lance K.
    Li, Jing
    Vaishampayan, Ulka
    Harper, Felicity
    Pemberton, Pam
    Sarkar, Fazlul H.
    AMERICAN JOURNAL OF TRANSLATIONAL RESEARCH, 2010, 2 (04): : 402 - 411
  • [3] Role of BioResponse 3,3′-Diindolylmethane in the Treatment of Human Prostate Cancer: Clinical Experience
    Li, Yiwei
    Sarkar, Fazlul H.
    MEDICAL PRINCIPLES AND PRACTICE, 2016, 25 : 11 - 17
  • [4] Phase Ib placebo-controlled, tissue biomarker trial of diindolylmethane (BR-DIMNG) in patients with prostate cancer who are undergoing prostatectomy
    Gee, Jason R.
    Saltzstein, Daniel R.
    Messing, Edward
    Kim, KyungMann
    Kolesar, Jill
    Huang, Wei
    Havighurst, Thomas C.
    Harris, Linda
    Wollmer, Barbara W.
    Jarrard, David
    House, Margaret
    Parnes, Howard
    Bailey, Howard H.
    EUROPEAN JOURNAL OF CANCER PREVENTION, 2016, 25 (04) : 312 - 320
  • [5] Dietary supplement 3,3′-diindolylmethane (DIM) as an antiangiogenic agent in breast cancer
    Ben Rahoma, Ghada M.
    Tuli, Neha Y.
    Bednarczyk, Robert B.
    Maniyar, Rachana R.
    Mittelman, Abraham
    Geliebter, Jan
    Tiwari, Raj
    CANCER RESEARCH, 2016, 76
  • [6] The potential efficacy of 3,3′-diindolylmethane in prevention of prostate cancer development
    Fares, Fuad
    Azzam, Naiel
    Appel, Boaz
    Fares, Basem
    Stein, Avi
    EUROPEAN JOURNAL OF CANCER PREVENTION, 2010, 19 (03) : 199 - 203
  • [7] Therapeutic activity of 3,3′-diindolylmethane on prostate cancer in an in vivo model
    Nachshon-Kedmi, M
    Fares, FA
    Yannai, S
    PROSTATE, 2004, 61 (02): : 153 - 160
  • [8] Inactivation of uPA and Its Receptor uPAR by 3,3′-Diindolylmethane (DIM) Leads to the Inhibition of Prostate Cancer Cell Growth and Migration
    Ahmad, Aamir
    Kong, Dejuan
    Sarkar, Sanila H.
    Wang, Zhiwei
    Banerjee, Sanjeev
    Sarkar, Fazlul H.
    JOURNAL OF CELLULAR BIOCHEMISTRY, 2009, 107 (03) : 516 - 527
  • [9] 3,3′-Diindolylmethane Inhibits Prostate Cancer Development in the Transgenic Adenocarcinoma Mouse Prostate Model
    Cho, Han Jin
    Park, So Young
    Kim, Eun Ji
    Kim, Jin-Kyung
    Park, Jung Han Yoon
    MOLECULAR CARCINOGENESIS, 2011, 50 (02) : 100 - 112
  • [10] 3,3′-diindolylmethane (DIM) induces apoptosis and cell cycle arrest in human colon cancer cells
    Park, J. N. H.
    Kim, Eun Ji
    Kwon, Dae Young
    Choi, Hyun J.
    Park, So Young
    Shin, Hyun-Kyung
    Surh, Young-Joon
    GASTROENTEROLOGY, 2006, 130 (04) : A118 - A118
12345